GlassScriptPhysician profile
Regina Nicholson
NPI 1891274809
$3,226.39
in general payments reported to CMS, 2019-2025
27 companies · $910 in 2025
The $910 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $670 · 2022: $998 · 2023: $405 · 2024: $243 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484 · Education: $73.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.46 |
| Education | $73.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $484.66 | 2021-2024 | Taltz, Olumiant |
| Novartis Pharmaceuticals Corporation | $424.20 | 2021-2025 | |
| Abbvie INC. | $356.00 | 2021-2025 | |
| Janssen Biotech, INC. | $304.39 | 2021-2025 | Tremfya, Remicade, Stelara |
| Galderma Laboratories, L.P. | $194.11 | 2021-2025 | Nemluvio |
| Leo Pharma INC. | $182.95 | 2021-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $174.79 | 2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $152.31 | 2021-2024 | Dupixent |
| Sun Pharmaceutical Industries INC. | $149.38 | 2021-2025 | Ilumya |
| Paratek Pharmaceuticals, INC. | $115.22 | 2021 | |
| Kerecis Limited | $78.07 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Almirall LLC | $72.26 | 2025 | Klisyri |
| Ucb, INC. | $64.43 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $59.50 | 2022-2023 | |
| Incyte Corporation | $58.66 | 2021-2025 | Opzelura |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $53.31 | 2022-2023 | Sotyktu |
| Medimetriks Pharmaceuticals, INC. | $49.70 | 2025 | Neo-Synalar, Clindacin Etz |
| Genzyme Corporation | $44.36 | 2022-2025 | |
| Journey Medical Corporation | $37.44 | 2025 | |
| Mayne Pharma Commercial LLC | $31.17 | 2022 | |
| Strata Skin Sciences, INC. | $27.37 | 2025 | Xtrac |
| Organon LLC | $24.38 | 2025 | |
| Amgen INC. | $21.24 | 2022 | |
| Baxter Healthcare | $20.76 | 2022 | |
| Allergan, INC. | $18.84 | 2021 | |
| Janssen Scientific Affairs, LLC | $13.68 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.